Bio-Techne, Cell Signaling Technology announce partnership

Bio-Techne and Cell Signaling Technology announced the addition of Simple Western validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on a trusted and validated platform. Obtaining accurate data efficiently and fast is key to advancing drug discovery and development. This ongoing partnership will allow for an expanded menu of Simple Western validated antibodies for various targets across multiple disciplines